Effects of AMPK Activation on Insulin Sensitivity and Metabolism in Leptin-Deficient ob/ob Mice
Leptin
Male
0301 basic medicine
Insulin/metabolism
Ratolins (Animals de laboratori)
Physiology
Adenylate Kinase/metabolism
Leptin/genetics
Acetyl-CoA Carboxylase/metabolism
Fisiologia
Mice, Obese
Obese
Mice
03 medical and health sciences
Leptina
Esquelet
Obesity/metabolism
Genetics
Animals
Insulin
Obesity
Glucagon/metabolism
Phosphorylation
Muscle, Skeletal
Skeletal/drug effects
Skeleton
2. Zero hunger
Muscles
Músculs
Adenylate Kinase
Phosphorylation/drug effects
Insulin resistance
Glucagon
Lipid Metabolism
Metabolisme
Metabolism
Mice (Laboratory animals)
Muscle
Obesitat
Female
Resistència a la insulina
Insulin Resistance
Insulin Resistance/physiology
Genètica
Acetyl-CoA Carboxylase
DOI:
10.2337/db13-0670
Publication Date:
2014-02-01T05:08:14Z
AUTHORS (10)
ABSTRACT
AMP-activated protein kinase (AMPK) is a heterotrimeric complex, composed of a catalytic subunit (α) and two regulatory subunits (β and γ), which act as a metabolic sensor to regulate glucose and lipid metabolism. A mutation in the γ3 subunit (AMPKγ3R225Q) increases basal AMPK phosphorylation, while concomitantly reducing sensitivity to AMP. AMPKγ3R225Q (γ3R225Q) transgenic mice are protected against dietary-induced triglyceride accumulation and insulin resistance. We determined whether skeletal muscle–specific expression of AMPKγ3R225Q prevents metabolic abnormalities in leptin-deficient ob/ob (ob/ob-γ3R225Q) mice. Glycogen content was increased, triglyceride content was decreased, and diacylglycerol and ceramide content were unaltered in gastrocnemius muscle from ob/ob-γ3R225Q mice, whereas glucose tolerance was unaltered. Insulin-stimulated glucose uptake in extensor digitorum longus muscle during the euglycemic-hyperinsulinemic clamp was increased in lean γ3R225Q mice, but not in ob/ob-γ3R225Q mice. Acetyl-CoA carboxylase phosphorylation was increased in gastrocnemius muscle from γ3R225Q mutant mice independent of adiposity. Glycogen and triglyceride content were decreased after leptin treatment (5 days) in ob/ob mice, but not in ob/ob-γ3R225Q mice. In conclusion, metabolic improvements arising from muscle-specific expression of AMPKγ3R225Q are insufficient to ameliorate insulin resistance and obesity in leptin-deficient mice. Central defects due to leptin deficiency may override any metabolic benefit conferred by peripheral overexpression of the AMPKγ3R225Q mutation.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (49)
CITATIONS (31)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....